FDA Examines Fertility Method that Raises Ethics Questions
A fertility treatment in which the genetic material of three different people are combined to create an embryo that is free of certain genetic defects is under scrutiny by the Food and Drug Administration amid claims that the therapy could amount to creating "designer babies." More on the ethically complex method from The New York Times:
Could you be pregnant? Take our quiz to find out!